# Clinical Validation of New Injection Molded Flocked Nasopharyngeal Swabs in Response to the COVID-19 Pandemic

> **NCT04368260** · NA · COMPLETED · sponsor: **University of Virginia** · enrollment: 40 (actual)

## Conditions studied

- COVID19

## Interventions

- **DEVICE:** Control swab
- **DEVICE:** Prototype swab

## Key facts

- **NCT ID:** NCT04368260
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-24
- **Primary completion:** 2020-08-01
- **Final completion:** 2020-08-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2022-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04368260

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04368260, "Clinical Validation of New Injection Molded Flocked Nasopharyngeal Swabs in Response to the COVID-19 Pandemic". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04368260. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*